Search

Your search keyword '"Hasskarl, Jens"' showing total 4 results
Start Over Author "Hasskarl, Jens" Publication Year Range Last 3 years
4 results on '"Hasskarl, Jens"'

2. Use of a real-world synthetic control arm for direct comparison of lisocabtagene maraleucel and conventional therapy in relapsed/refractory large B-cell lymphoma

Author

Van Le, Hoa, primary, Van Naarden Braun, Kim, additional, Nowakowski, Grzegorz S., additional, Sermer, David, additional, Radford, John, additional, Townsend, William, additional, Ghesquieres, Herve, additional, Menne, Tobias, additional, Porpaczy, Edit, additional, Fox, Christopher P., additional, Schusterbauer, Claudia, additional, Liu, Fei Fei, additional, Yue, Lihua, additional, De Benedetti, Marc, additional, and Hasskarl, Jens, additional

Published
2023
Full Text
View/download PDF

3. Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma

Author

Makita, Shinichi, primary, Yamamoto, Go, additional, Maruyama, Dai, additional, Asano‐Mori, Yuki, additional, Kaji, Daisuke, additional, Ananthakrishnan, Revathi, additional, Ogasawara, Ken, additional, Stepan, Lara, additional, Schusterbauer, Claudia, additional, Rettby, Nils, additional, Hasskarl, Jens, additional, and Izutsu, Koji, additional

Published
2022
Full Text
View/download PDF

4. Additional file 1 of Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel

Author

Cartron, Guillaume, Fox, Christopher P., Liu, Fei Fei, Kostic, Ana, Hasskarl, Jens, Li, Daniel, Bonner, Ashley, Zhang, Yixie, Maloney, David G., and Kuruvilla, John

Subjects
animal structures, parasitic diseases
Abstract

Additional file 1: Table S1. Clinical factors included for primary and sensitivity analyses comparing liso-cel with tisagenlecleucel. Table S2. Comparison of clinical factors before and after MAIC for primary and sensitivity analyses of PFS in TRANSCEND and JULIET. Table S3. Comparison of clinical factors before and after MAIC for primary and sensitivity analyses of CR in TRANSCEND and JULIET. Table S4. Comparison of clinical factors before and after MAIC for primary and sensitivity analyses of ORR in TRANSCEND and JULIET. Table S5. Comparison of clinical factors before and after MAIC for safety analysis in TRANSCEND and JULIET.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results